Solventum Corp. (SOLV)
76.16
+1.90
(+2.57%)
USD |
NYSE |
May 18, 16:00
76.16
0.00 (0.00%)
After-Hours: 18:20
Solventum Research and Development Expense (Quarterly) : 186.00M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Align Technology, Inc. | 98.66M |
| Insulet Corp. | 89.70M |
| Envista Holdings Corp. | 30.00M |
| Dentsply Sirona, Inc. | 44.00M |
| Milestone Scientific, Inc. | 0.00 |